Gilead (GILD) Announces European CHMP Adopts Positive Opinion for Aztreonam Lysine

June 26, 2009 9:05 AM EDT Send to a Friend
Gilead Sciences, Inc. (Nasdaq: GILD) announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login